EUVIMEDEUVIMED entdecken
Crossref

HNRNPC lactylation promotes pancreatic cancer progression through mediating the alternative splicing of PAK6

BoHao Li, HanXiang Zhan, Fei Gao, MingXin Wen, Yunhan Ma, YuChen Xiu, ZhenYa Liu, KaiWei Huang, YunShan Wang, GuangWei Wei, YangMiao Duan

Cancer Letters · 2026-02 · 639 · 218230

DOI: 10.1016/j.canlet.2025.218230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-02. Verfasst von BoHao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Key Laboratory of Experimental Teratology, Ministry of Education, School of Basic Medical Sciences, Cheeloo College of…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Alternative Splicing, p21-Activated Kinases, Heterogeneous-Nuclear Ribonucleoprotein Group C. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Project of Shandong Province Higher Educational Science and Technology Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is a highly malignant and lethal tumor in gastrointestinal tract. Lactate accumulation is a classical feature of metabolic reprogramming in cancers. Lactate-derived lysine lactylation (Kla) is identified as a new type of post-translational modifications (PTMs), which is confirmed to be involved in multiple biological processes. However, the cancer-specific regulation of protein Kla in PC requires further elucidation. Here, we report a range of dysregulated Kla sites specifically related to RNA splicing in human pancreatic cancer, leading to the observation that the Kla at lysine 176 of heterogeneous nuclear ribonucleoprotein C (HNRNPC K176la) is significantly elevated in PC. Blocking HNRNPC K176la dramatically inhibits pancreatic cancer growth and metastasis. Mechanistically, K176la strengthened the binding of HNRNPC with poly-U motifs in p21-activated kinase 6 (PAK6) pre-mRNA, facilitating the expression of the oncogenic isoform PAK6S. Therefore, our study identifies a number of cancer-specific Kla sites spanned on alternative splicing (AS)-related proteins and unravels the significance of HNRNPC K176la in RNA splicing and PC development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAlternative Splicingp21-Activated KinasesHeterogeneous-Nuclear Ribonucleoprotein Group CHumansAnimalsCell Line, TumorMiceDisease ProgressionGene Expression Regulation, NeoplasticProtein Processing, Post-TranslationalCell ProliferationMice, NudeLysine

Stichwörter der Autor:innen

Alternative splicingHNRNPCLactylationPAK6Pancreatic cancer

Substanzen

p21-Activated KinasesHeterogeneous-Nuclear Ribonucleoprotein Group CHNRNPC protein, humanLysine

Autor:innen und Institutionen

  • Department of Cell Biology and Key Laboratory of Experimental Teratology, Ministry of Education, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
  • Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, 250012, China.
  • Department of Anatomy, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
  • Department of Thyroid and Breast Surgery, The 960th Hospital of the Chinese People's Liberation Army (PLA) Joint Logistics Support Force, Jinan, Shandong, 250012, China.
  • Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
  • Department of Cell Biology and Key Laboratory of Experimental Teratology, Ministry of Education, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. Electr…

Förderung

  • Shandong Province Natural Science Foundation
  • Project of Shandong Province Higher Educational Science and Technology Program
  • National Natural Science Foundation of China

Zitieren

APA

Li, B., Zhan, H., Gao, F., Wen, M., Ma, Y., Xiu, Y., Liu, Z., Huang, K., Wang, Y., Wei, G., & Duan, Y. (2026). HNRNPC lactylation promotes pancreatic cancer progression through mediating the alternative splicing of PAK6. Cancer Letters, 639, 218230. https://doi.org/10.1016/j.canlet.2025.218230

Vancouver

Li B, Zhan H, Gao F, Wen M, Ma Y, Xiu Y, et al. HNRNPC lactylation promotes pancreatic cancer progression through mediating the alternative splicing of PAK6. Cancer Letters. 2026;639:218230. doi:10.1016/j.canlet.2025.218230

BibTeX
@article{Li2026,
  author = {Li, BoHao and Zhan, HanXiang and Gao, Fei and Wen, MingXin and Ma, Yunhan and Xiu, YuChen and Liu, ZhenYa and Huang, KaiWei and Wang, YunShan and Wei, GuangWei and Duan, YangMiao},
  title = {HNRNPC lactylation promotes pancreatic cancer progression through mediating the alternative splicing of PAK6},
  journal = {Cancer Letters},
  year = {2026},
  volume = {639},
  pages = {218230},
  doi = {10.1016/j.canlet.2025.218230}
}
Kostenlos starten →